Citius Pharmaceuticals, Inc. (CTXR)
0.5107
-0.01
(-1.56%)
USD |
NASDAQ |
Nov 18, 16:00
0.5183
+0.01
(+1.49%)
After-Hours: 20:00
Citius Pharmaceuticals Price to Book Value : 0.2105 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 0.2105 |
| November 17, 2026 | 0.2138 |
| November 16, 2026 | 0.2174 |
| November 13, 2026 | 0.2205 |
| November 12, 2026 | 0.2194 |
| November 11, 2026 | 0.1981 |
| November 10, 2026 | 0.2031 |
| November 09, 2026 | 0.2169 |
| November 06, 2026 | 0.2246 |
| November 05, 2026 | 0.2297 |
| November 04, 2026 | 0.2271 |
| November 03, 2026 | 0.2362 |
| November 02, 2026 | 0.2316 |
| October 30, 2026 | 0.2156 |
| October 29, 2026 | 0.2321 |
| October 28, 2026 | 0.223 |
| October 27, 2026 | 0.2067 |
| October 26, 2026 | 0.1852 |
| October 23, 2026 | 0.1662 |
| October 22, 2026 | 0.1528 |
| October 21, 2026 | 0.163 |
| October 20, 2026 | 0.1721 |
| October 19, 2026 | 0.1763 |
| October 16, 2026 | 0.1896 |
| October 15, 2026 | 0.1896 |
| Date | Value |
|---|---|
| October 14, 2026 | 0.1916 |
| October 13, 2026 | 0.1962 |
| October 12, 2026 | 0.2031 |
| October 09, 2026 | 0.2058 |
| October 08, 2026 | 0.2014 |
| October 07, 2026 | 0.2065 |
| October 06, 2026 | 0.1981 |
| October 05, 2026 | 0.2143 |
| October 02, 2026 | 0.2191 |
| October 01, 2026 | 0.2226 |
| September 30, 2026 | 0.2188 |
| September 29, 2026 | 0.2285 |
| September 28, 2026 | 0.2263 |
| September 25, 2026 | 0.2385 |
| September 24, 2026 | 0.235 |
| September 23, 2026 | 0.2343 |
| September 22, 2026 | 0.2465 |
| September 21, 2026 | 0.2376 |
| September 18, 2026 | 0.2473 |
| September 17, 2026 | 0.2423 |
| September 16, 2026 | 0.2308 |
| September 15, 2026 | 0.2308 |
| September 14, 2026 | 0.2362 |
| September 11, 2026 | 0.2394 |
| September 10, 2026 | 0.2412 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.569 |
| Corcept Therapeutics, Inc. | 8.892 |
| Veru, Inc. | 1.388 |
| Johnson & Johnson | 8.051 |
| Eli Lilly & Co. | 32.32 |
Price to Book Value Related Metrics
| PS Ratio | 1.583 |
| Price | 0.5107 |
| Earnings Yield | -413.2% |
| Market Cap | 14.02M |